Lipids, Nutrition and Cardiovascular Prevention Clinic

 

Lipids, Nutrition and Cardiovascular Prevention Clinic under the direction of Dr. Sophie Bernard

The Lipids, Nutrition and Cardiovascular Prevention Clinic of the Montreal Clinical Research Institute (IRCM) assesses and treats the elevated blood cholesterol cases and other fats in the blood, as well as the risks of cardiovascular or metabolic diseases. To better understand the origin of these lipid disorders and their complications, the Institute's research team is studying the nutritional, biochemical, genetic, molecular and pharmacological aspects of these issues to offer new and more effective treatments and to reduce complications.

Sophie Bernard

Clinic Director - Head of the Rare Disease Clinic

Phone:
514 987-5582

Physician and researcher, Sophie Bernard is a specialist in endocrinology and metabolic diseases. Dr. Sophie Bernard also practices medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and she is an Associate Professor in the Department of Medicine at the Faculty of Medicine of Université de Montréal. Dr. Bernard is the author and co-author of several scientific publications. She completed her medical degree at the University Claude Bernard-Lyon 1, in France, and obtained a specialization in endocrinology metabolism and nutrition as well as a PhD in biology of vascular diseases and a sub-specialization in lipid metabolism at the same university.

Other(s) function(s)

Alexis Baass
Associate Director
Phone:
514 987-5650
Catherine Beauregard
Physician
Chantal Blais
Nutritionist
Phone:
514 987-5648
Lucienne Bourque
Nurse
Phone:
514 987-5652
Patrick du Souich
Physician
Phone:
514 987-3258
Andréanne Fortin
Nutritionist
Phone:
514 987-5589
Martine Gauthier
Head Nurse
Phone:
514 987-5552
Sylvain L'Abbé
Clerk
Khiem Nguyen
Administrative Technician
Phone:
514 987-5666
Sylvie Ott-Braschi
Physician
Martine Paquette
Research Coordinator
Ghislaine Roederer
Physician
Nathalie St-Pierre
Nurse
Phone:
514 987-5653
Ewa Wesolowska
Physician

Publications

Paquette M, Amyot J, Fantino M, Baass A, Bernard S. Rare variants in triglycerides-related genes increase pancreatitis risk in multifactorial chylomicronemia syndrome.J Clin Endocrinol Metab. 2021:dgab360.

Béland-Bonenfant S, Paquette M, Fantino M, et al. Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients with Familial Hypercholesterolemia. CJC Open. 2020.

Paquette M, Fantino M, Bernard S, Baass A. The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia. J Clin Lipidol. 2020;14(5):660-666.

Paquette M, Bernard S, Blank D, Paré G, Baass A. A simplified diagnosis algorithm for dysbetalipoproteinemia. J Clin Lipidol. 2020;14(4):431-37.

Gaudet D, Stevenson M, Komari N, Trentin G, Crowson C, Hadlker N, Bernard S. The burden of familial chylomicronemia syndrome in Canadian patients. Lipids Health Dis. 2020;19(1):120.

Paquette M, Gauthier D, Chamberland A, Prat A, De Lucia Rolfe E, Rasmussen JJ, Kaduka L, Seidah NG, Bernard S, Christensen DL, Baass A. Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis. Clin Biochem. 2020;77:20-5. 

Baass A, Paquette M, Bernard S, Hegele RA. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. J Intern Med. 2020;287(4):340-8.

Paquette M, Bernard S, Paré G, Baass A. Triglycerides, hypertension, and smoking predict cardiovascular disease in dysbetalipoproteinemia. J Clin Lipidol. 2020;14(1):46-52. 

Paquette M, Bernard S, Thanassoulis G, Baass A. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia. J Clin Lipidol. 2019;13(4):627-633.e1. 

Paquette M, Bernard S, Baass A. SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia. Clin Biochem. 2019;66:44-8.
See more publications + See less publications -